International Trends in the Incidence of Testicular Cancer, 1973-2002

Abstract

Background: Whereas testicular cancer incidence rates have been widely reported in populations of Northern European ancestry, rates in other populations have been less frequently examined. In a prior report, global testicular cancer incidence rates and trends for the years 1973 to 1997 were summarized. The current report extends these analyses with an additional 5 years of data from Cancer Incidence in Five Continents.Methods: Age-standardized incidence rates over successive 5-year time periods were obtained for populations in the Americas, Asia, Europe, and Oceania.Results: In general, testicular cancer incidence remained highest in Northern European populations (8.0-9.0 per 100,000) and lowest in Asian and African populations (<1 per 100,000). One notable exception to this pattern, however, was the very high rate reported by the Valdivia, Chile registry (8.8 per 100,000). In many populations, rates rose between 1973 and 2002, although the increases were strongest and most consistent among populations of European ancestry. In certain European populations, such as those of Denmark and of Geneva, Switzerland, some recent plateauing of rates was evident. There was little evidence of increase and possible evidence of a modest decline in rates among east Asian populations. Trends by histology (seminoma and nonseminoma) were generally similar to one another.Conclusions: Risk of testicular cancer remains relatively high in Northern European populations and low in Asian and African populations. Similar trends by histology suggest common risk factors.Effect: Reasons for increasing rates among Northern Europeans and stable or declining rates among East Asians are unexplained, supporting the need for future etiologic studies. Cancer Epidemiol Biomarkers Prev; 19(5);

Clinicopathological Features and Survival of Young Turkish Patients with Testicular Germ Cell Tumors

“…When the distribution of the patients according to stage were evaluated, it was seen that a vast majority of the patients were at an early stage and only 22.9% of them were at an advanced stage at the time of diagnosis. These findings are consistent with the findings of previous studies (Bosl et al, 1997;Dieckmann et al, 2004;Eble et al, 2004;Chia et al, 2010).…”

Clinicopathology Illustration Treatment Options and Survival in the Patients with Testicular Germ Cell Tumors in Kermanshah Province, Iran

“…A study on epidemiology of TGCT showed that seminoma was the most common testicular cancer in majority of countries with tumor registries (11). Among TGCT patients, 50% were seminomatous tumors, 48% nonseminomatous tumors and 2% were spermatocytic seminomas (12).…”

AXIN1 protects against testicular germ cell tumors via the PI3K/AKT/mTOR signaling pathway

“…Testicular germ cell tumors (TGCTs) are relatively rare, representing ~1-1.5% of all malignancies diagnosed in males and ~5% of urological tumors in males in general (1). However, TGCTs are the most frequently observed solid tumor among men aged between 15 and 35 years old (2).…”